Biology and Pharmacology Risk Split
Definition
Biotech risk decomposes into whether the target is truly involved in disease (biology) and whether a drug can safely modulate it in the body (pharmacology), both hard to predict in advance.
Cast within
No topic-region cast yet — this appears once Biology and Pharmacology Risk Split's compiled claims are aligned into a topic region's argument tree.
Claims mentioning Biology and Pharmacology Risk Split (3)
Your notes
Loading notes...